|
1
|
Al-Owain M, Kaya N, Al-Zaidan H, Al-Hashmi
N, Al-Bakheet A, Al-Muhaizea M, Chedrawi A, Basran RK and Milunsky
A: Novel intragenic deletion in OPHN1 in a family causing XLMR with
cerebellar hypoplasia and distinctive facial appearance. Clin
Genet. 79:363–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Borck G, Molla-Herman A, Boddaert N,
Encha-Razavi F, Philippe A, Robel L, Desguerre I, Brunelle F,
Benmerah A, Munnich A and Colleaux L: Clinical, cellular, and
neuropathological consequences of AP1S2 mutations: Further
delineation of a recognizable X-linked mental retardation syndrome.
Hum Mutat. 29:966–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma QL, Yang F, Frautschy SA and Cole GM:
PAK in Alzheimer disease, Huntington disease and X-linked mental
retardation. Cell Logist. 2:117–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lossi AM, Millan JM, Villard L, Orellana
C, Cardoso C, Prieto F, Fontés M and Martínez F: Mutation of the
XNP/ATR-X gene in a family with severe mental retardation, spastic
paraplegia and skewed pattern of X inactivation: Demonstration that
the mutation is involved in the inactivation bias. Am J Hum Genet.
65:558–562. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Badura-Stronka M, Jamsheer A,
Materna-Kiryluk A, Sowińska A, Kiryluk K, Budny B and
Latos-Bieleńska A: A novel nonsense mutation in CUL4B gene in three
brothers with X-linked mental retardation syndrome. Clin Genet.
77:141–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
des Portes V: X-linked mental deficiency.
Handb Clin Neurol. 111:297–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stevenson RE, Abidi F, Schwartz CE, Lubs
HA and Holmes LB: Holmes-Gang syndrome is allelic with
XLMR-hypotonic face syndrome. Am J Med Genet. 94:383–385. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chudley AE, Lowry RB and Hoar DI: Mental
retardation, distinct facial changes, short stature, obesity, and
hypogonadism: A new X-linked mental retardation syndrome. Am J Med
Genet. 31:741–751. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
du Souich C, Chou A, Yin J, Oh T, Nelson
TN, Hurlburt J, Arbour L, Friedlander R, McGillivray BC, Tyshchenko
N, et al: Characterization of a new X-linked mental retardation
syndrome with microcephaly, cortical malformation, and thin
habitus. Am J Med Genet A 149A. 2469–2478. 2009. View Article : Google Scholar
|
|
10
|
Smith RD, Fineman RM and Myers GG: Short
stature, psychomotor retardation, and unusual facial appearance in
two brothers. Am J Med Genet. 7:5–9. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stephenson LD and Johnson JP:
Smith-Fineman-Myers syndrome: Report of a third case. Am J Med
Genet. 22:301–304. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei J, Chen B, Jiang Y, Yang Y and Guo Y:
Smith-Fineman-Myers syndrome: Report on a large family. Am J Med
Genet. 47:307–311. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McPherson EW, Clemens MM, Gibbons RJ and
Higgs DR: X-linked alpha-thalassemia/mental retardation (ATR-X)
syndrome: a new kindred with severe genital anomalies and mild
hematologic expression. Am J Med Genet. 55:302–306. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gibbons RJ and Higgs DR:
Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet.
97:204–212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gibbons RJ, Picketts DJ, Villard L and
Higgs DR: Mutations in a putative global transcriptional regulator
cause X-linked mental retardation with alpha-thalassemia (ATR-X
syndrome). Cell. 80:837–845. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schenkel LC, Kernohan KD, McBride A, Reina
D, Hodge A, Ainsworth PJ, Rodenhiser DI, Pare G, Bérubé NG, Skinner
C, et al: Identification of epigenetic signature associated with
alpha thalassemia/mental retardation X-linked syndrome. Epigenetics
Chromatin. 10:102017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang P, Park DJ, Marshall Graves JA and
Harley VR: ATRX and sex differentiation. Trends Endocrinol Metab.
15:339–344. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Villard L and Fontes M:
Alpha-thalassemia/mental retardation syndrome, X-Linked (ATR-X, MIM
#301040, ATR-X/XNP/XH2 gene MIM #300032). Eur J Hum Genet.
10:223–225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiurazzi P, Tabolacci E and Neri G:
X-linked mental retardation (XLMR): From clinical conditions to
cloned genes. Crit Rev Clin Lab Sci. 41:117–158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abidi FE, Cardoso C, Lossi AM, Lowry RB,
Depetris D, Mattéi MG, Lubs HA, Stevenson RE, Fontes M, Chudley AE
and Schwartz CE: Mutation in the 5′alternatively spliced region of
the XNP/ATR-X gene causes Chudley-Lowry syndrome. Eur J Hum Genet.
13:176–183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De La Fuente R, Viveiros MM, Wigglesworth
K and Eppig JJ: ATRX, a member of the SNF2 family of
helicase/ATPases, is required for chromosome alignment and meiotic
spindle organization in metaphase II stage mouse oocytes. Dev Biol.
272:1–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Picketts DJ, Higgs DR, Bachoo S, Blake DJ,
Quarrell OW and Gibbons RJ: ATRX encodes a novel member of the SNF2
family of proteins: Mutations point to a common mechanism
underlying the ATR-X syndrome. Hum Mol Genet. 5:1899–1907. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villard L, Gecz J, Mattéi JF, Fontés M,
Saugier-Veber P, Munnich A and Lyonnet S: XNP mutation in a large
family with Juberg-Marsidi syndrome. Nat Genet. 12:359–360. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong LH, McGhie JD, Sim M, Anderson MA,
Ahn S, Hannan RD, George AJ, Morgan KA, Mann JR and Choo KH: ATRX
interacts with H3.3 in maintaining telomere structural integrity in
pluripotent embryonic stem cells. Genome Res. 20:351–360. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Villard L, Fontès M, Adès LC and Gecz J:
Identification of a mutation in the XNP/ATR-X gene in a family
reported as Smith-Fineman-Myers syndrome. Am J Med Genet. 91:83–85.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abidi F, Schwartz CE, Carpenter NJ,
Villard L, Fontes M and Curtis M: Carpenter-Waziri syndrome results
from a mutation in XNP. Am J Med Genet. 85:249–251. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian X, Li J, Xu S, Wan Y, Li Y, Jiang Y,
Zhao H, Zhou Y, Liao J, Liu H, et al: Prenatal exposure to
phthalates and neurocognitive development in children at two years
of age. Environ Int. 131:1050232019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guion-Almeida ML, Tabith A Jr,
Kokitsu-Nakata NM and Zechi RM: Smith-Fineman-Myers syndrome in
apparently monozygotic twins. Am J Med Genet. 79:205–208. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Budny B, Badura-Stronka M, Materna-Kiryluk
A, Tzschach A, Raynaud M, Latos-Bielenska A and Ropers HH: Novel
missense mutations in the ubiquitination-related gene UBE2A cause a
recognizable X-linked mental retardation syndrome. Clin Genet.
77:541–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giannandrea M, Bianchi V, Mignogna ML,
Sirri A, Carrabino S, D'Elia E, Vecellio M, Russo S, Cogliati F,
Larizza L, et al: Mutations in the small GTPase gene RAB39B are
responsible for X-linked mental retardation associated with autism,
epilepsy, and macrocephaly. Am J Hum Genet. 86:185–195. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huo L, Teng Z, Wang H and Liu X: A novel
splice site mutation in AP1S2 gene for X-linked mental retardation
in a Chinese pedigree and literature review. Brain Behav.
9:e012212019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dyer MA, Qadeer ZA, Valle-Garcia D and
Bernstein E: ATRX and DAXX: Mechanisms and mutations. Cold Spring
Harb Perspect Med. 7(pii): a0265672017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haase S, Garcia-Fabiani MB, Carney S,
Altshuler D, Núñez FJ, Méndez FM, Núñez F, Lowenstein PR and Castro
MG: Mutant ATRX: Uncovering a new therapeutic target for glioma.
Expert Opin Ther Targets. 22:599–613. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gibbons RJ, Bachoo S, Picketts DJ, Aftimos
S, Asenbauer B, Bergoffen J, Berry SA, Dahl N, Fryer A, Keppler K,
et al: Mutations in transcriptional regulator ATRX establish the
functional significance of a PHD-like domain. Nat Genet.
17:146–148. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nandakumar P, Mansouri A and Das S: The
role of ATRX in glioma biology. Front Oncol. 7:2362017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Juhasz S, Elbakry A, Mathes A and Löbrich
M: ATRX promotes DNA repair synthesis and sister chromatid exchange
during homologous recombination. Mol Cell. 71:11–24.e7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Badens C, Lacoste C, Philip N, Martini N,
Courrier S, Giuliano F, Verloes A, Munnich A, Leheup B, Burglen L,
et al: Mutations in PHD-like domain of the ATRX gene correlate with
severe psychomotor impairment and severe urogenital abnormalities
in patients with ATRX syndrome. Clin Genet. 70:57–62. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ng SB, Buckingham KJ, Lee C, Bigham AW,
Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, et
al: Exome sequencing identifies the cause of a mendelian disorder.
Nat Genet. 42:30–35. 2009. View
Article : Google Scholar : PubMed/NCBI
|
